VitaNova Life Sciences Corp (VNOV) Revenue (2017 - 2026)

VitaNova Life Sciences (VNOV) has reported Revenue for 7 consecutive years, with $709625.0 the latest figure, recorded in Q1 2026.

• Revenue for Q1 2026 came in at $709625.0, up 130.16% year-over-year; the trailing twelve-month figure through Jan 2026 was $3.2 million (up 154.79% YoY), and the FY2025 annual result was $2.7 million, up 366.47% from the prior year.
• Revenue was $709625.0 for Q1 2026 at VitaNova Life Sciences, up from $427115.0 in the prior quarter.
• Over five years, Revenue peaked at $2.0 million in Q2 2025 and troughed at $3000.0 in Q2 2023.
• Average Revenue over 5 years is $305762.5, with a median of $103899.0 recorded in 2025.
• Year-over-year, Revenue sank 93.33% in 2023 and soared 18053.13% in 2024.
• Over 5 years, Revenue stood at $10000.0 in 2022, then sank by 70.0% to $3000.0 in 2023, then jumped by 9637.27% to $292118.0 in 2024, then soared by 46.21% to $427115.0 in 2025, then surged by 66.14% to $709625.0 in 2026.
• Per Business Quant data, the three most recent Revenue figures were $709625.0 in Q1 2026, $427115.0 in Q4 2025, and $103899.0 in Q3 2025.